MedPath

Inspiratory Muscle Training in Patients With COVID-19

Not Applicable
Terminated
Conditions
Covid19
Respiratory Disease
Interventions
Device: power breathe
Registration Number
NCT04603963
Lead Sponsor
Elaine Cristina Pereira <elaine.cpereira@einstein.br>
Brief Summary

COVID 19 has become a pandemic and has led to high demand on healthcare systems. It can cause a severe acute respiratory syndrome (SARS CoV-2) which leads to a long hospital stay, developing important functional damage and making hospital discharge difficult. Elderly, obese and people with chronic diseases are more susceptible to contracting the disease, this profile of patients already has a predisposition for respiratory muscle weakness and in this context, after clinical stability, it is still necessary in a hospital environment to approach respiratory and motor physiotherapy. to optimize the recovery of these patients. Objective: Improved breathing, functionality, exercise capacity and muscle strength in non-critical patients. Method: Prospective randomized clinical study where one group received motor and respiratory physiotherapy and the other group performed the same therapy associated with inspiratory muscle training. Results: The findings will be compared before and after the approach and will be presented in graphs and tables. Statistical tests will be used considering a significance level of 5%.

Detailed Description

Prospective clinical study in patients with COVID-19 admitted to a non-critical unit of a tertiary hospital. They were randomized into a group that received motor and respiratory exercises and another group that received the same exercises associated with respiratory muscle training.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
55
Inclusion Criteria
  • patients diagnosed with COVID-19 through PCR aged over 18 years admitted to non-critical units.
Exclusion Criteria
  • patients with changes in the level of consciousness and non-transient understanding, exclusive palliative care without prognosis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
intervention grouppower breatheHe received the same intervention as the control group, associating respiratory muscle training 1 time a day with power breathe 3 series of 10 repetitions (started with 30% of the Pimax value) with readjusted load every 7 days.
Primary Outcome Measures
NameTimeMethod
impact on functionality14 days

respiratory muscle training appears to impact functionality

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Municipal Hospital Vila Santa Catarina

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath